Improving Supply Chain Management and Commodity Security
Photo credit: Jamshid Noori/SPS AfghanistanSupporting better pharmaceutical supply management helps prevent medicine stock-outs. SPS worked to strengthen each link of the medicine supply chain to help ensure access to and availability of affordable medicines. Building upon previous USAID projects, SPS integrated project drug management staff, infrastructure, and responsibilities into the current pharmaceutical framework. It also helped develop an operational plan to build the capacity of the General Directorate of Pharmaceutical Affairs to assume responsibility for procurement, storage, and distribution.
The project supported the establishment of a Joint Pooled Procurement Committee and Pooled Procurement Management Unit. It also finalized a Quantification, Procurement, and Distribution Guideline to standardize the process of procurement planning, operations, and medicine distribution from warehouses to health facilities.
The project supported the development of stock management standard operating procedures for pharmaceutical enterprises and refurbished the MoPH Central Medical Store to promote good storage practices. The average availability of medicines in associated health facilities in 13 provinces increased from 89% to more than 93% in 2015. With the inclusion of provinces not provided with technical assistance in fiscal year 2016, the indicator worsened. The equivalent of 1,242,158 couple-years protection of modern contraceptive methods was provided for distribution at Basic Package of Health Services (BPHS) health facilities.
SPS piloted a portable Minilab project to test imported medicines from private- and public-sector facilities in the provinces of Kabul, Kandahar, Herat, Nangarhar, Balkh, and Kundu. The pilot showed the intervention has the potential to more efficiently conduct medicine screening at various points in the supply chain.
SPS supported the development of a new National Policy for Waste Management and Safe Disposal of Pharmaceutical Products and a National Policy for Narcotic and Controlled Medicines.